Eliminated patient fee and changes in dispensing patterns of asthma medication in children-An interrupted time series analysis

被引:23
作者
Dahlen, Elin [1 ,2 ]
Komen, Joris [2 ,3 ]
Jonsson, Eva W. [4 ]
Almqvist, Catarina [5 ,6 ]
Kull, Inger [7 ,8 ]
Wettermark, Bjorn [1 ,2 ]
机构
[1] Karolinska Inst, Ctr Pharmacoepidemiol, Dept Med, Stockholm, Sweden
[2] Stockholm Cty Council, Publ Healthcare Serv Comm, Stockholm, Sweden
[3] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands
[4] Karolinska Univ Hosp, Karolinska Inst, Dept Med Solna, Clin Pharmacol,Clin Epidemiol, Stockholm, Sweden
[5] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[6] Karolinska Univ Hosp, Pediat Allergy & Pulmonol Unit, Astrid Lindgren Childrens Hosp, Stockholm, Sweden
[7] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden
[8] Sachs Children & Youth Hosp, Sodersjukhuset, Stockholm, Sweden
关键词
asthma; co-payment; drug utilization; interrupted time series analysis; patient fee; INHALED CORTICOSTEROIDS; PRESCRIPTIONS;
D O I
10.1111/bcpt.13268
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In 2016, all prescription drugs included in the reimbursement system in Sweden were made available for children (age 0-17 years) without any patient fees. Our aim was to estimate the association between this intervention and the dispensing patterns of asthma medications among children. Dispensing data on asthma medications for all children living in Stockholm County during 2014-2017 were selected to include two years before (January 2014-December 2015) and after (January 2016-December 2017) the intervention. In an uncontrolled before and after study, the measures of utilization were as follows: the proportion of children with at least one dispensed asthma medication (prevalence); the number of children initiated on treatment after an 18-month drug-free period (incidence); the number of defined daily doses (DDDs) dispensed per child; and the number of children with at least two prescriptions with controller medication (inhaled corticosteroid or leukotriene receptor antagonist) dispensed during 18 months (persistence). In an interrupted time series (ITS) analysis, all measures were included except for persistence. Socio-economic status was defined using Mosaic data. The prevalence increased after the intervention (from 11.9% to 13.0%). However, the ITS analysis showed a positive trend already before the intervention, and consequently, the increase was not attributable to the intervention. For incidence, similar patterns were observed. There was an increase in dispensed volumes related to the intervention, 46.3 DDDs/child/month before and 51.1 after the intervention (P-value 0.01). The proportion of children with persistent asthma medication increased from 46.0% to 51.9% in children with low socio-economic status. In conclusion, the intervention was only modestly associated with changes in the dispensing patterns of asthma medication, with the volume dispensed per child increasing slightly, particularly in children with low socio-economic status.
引用
收藏
页码:360 / 369
页数:10
相关论文
共 29 条
  • [21] Kozyrskyj AL, 2001, ARCH PEDIAT ADOL MED, V155, P1219
  • [22] Pharmaceutical policies: effects of cap and co-payment on rational use of medicines
    Luiza, Vera Lucia
    Chaves, Luisa A.
    Silva, Rondineli M.
    Emmerick, Isabel Cristina M.
    Chaves, Gabriela C.
    Fonseca de Araujo, Silvia Cristina
    Moraes, Elaine L.
    Oxman, Andrew D.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (05):
  • [23] Lundberg O, 2006, SWEDISH COMMISSION E
  • [24] Insights into social disparities in smoking prevalence using Mosaic, a novel measure of socioeconomic status: an analysis using a large primary care dataset
    Sharma, Aarohi
    Lewis, Sarah
    Szatkowski, Lisa
    [J]. BMC PUBLIC HEALTH, 2010, 10
  • [25] The Effect of Copayments for Prescriptions on Adherence to Prescription Medicines in Publicly Insured Populations; A Systematic Review and Meta-Analysis
    Sinnott, Sarah-Jo
    Buckley, Claire
    O'Riordan, David
    Bradley, Colin
    Whelton, Helen
    [J]. PLOS ONE, 2013, 8 (05):
  • [26] Relationship of asthma management, socioeconomic status, and medication insurance characteristics to exacerbation frequency in children with asthma
    Ungar, Wendy J.
    Paterson, J. Michael
    Gomes, Tara
    Bikangaga, Peter
    Gold, Milton
    To, Teresa
    Kozyrskyj, Anita L.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 106 (01) : 17 - 23
  • [27] Segmented regression analysis of interrupted time series studies in medication use research
    Wagner, AK
    Soumerai, SB
    Zhang, F
    Ross-Degnan, D
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2002, 27 (04) : 299 - 309
  • [28] The First Decade with the Swedish Prescribed Drug Register - A Systematic Review of the Output in the Scientific Literature
    Wallerstedt, Susanna M.
    Wettermark, Bjorn
    Hoffmann, Mikael
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 (05) : 464 - 469
  • [29] Wettermark B, 2009, APPL HEALTH ECON HEA, V7, P137, DOI 0.2165/11314810-000000000-00000